Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT07912008
PHASE4

Clinical Study on the Efficacy and Safety of Heyan® Kuntai Capsules in Alleviating Perimenopausal Symptoms Induced by GnRH-a

Sponsor: Xintian Pharmaceutical

View on ClinicalTrials.gov

Summary

The goal of this clinical trial is to learn if Kuntai capsule works to treat perimenopausal symptoms caused by GnRH-a in adults. It will also learn about the safety of Kuntai capsule.

Official title: Clinical Study on the Efficacy and Safety of Heyan® Kuntai Capsules in Relieving Perimenopausal Symptoms Induced by GnRH-a-A Multicenter, Prospective, Randomized, Double-Blind, Placebo-Controlled Trial

Key Details

Gender

FEMALE

Age Range

18 Years - 45 Years

Study Type

INTERVENTIONAL

Enrollment

162

Start Date

2024-09-26

Completion Date

2026-02-11

Last Updated

2026-11-03

Healthy Volunteers

No

Interventions

DRUG

Kuntai Capsule

The ingredients include rehmannia glutinosa, coptis chinensis, white peony root, scutellaria baicalensis, donkey-hide gelatin, and poria cocos.

DRUG

Placebo

The shape, color, smell and taste are all similar to Kuntai Capsules.

Locations (1)

Peking University People's Hospital

Beijing, Beijing Municipality, China